$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Rawlins Michael | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 1,275 | 0 | 1,275 | 0 to 1.3 K |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 978 | 0 | 978 | 0 to 978 |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 1,245 | 0 | 1,245 | 0 to 1.2 K |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Sanchez Juan F. | VP, Corp. Communica ... | Option Exercise | A | 16.86 | 90,000 | 1,517,400 | 90,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 16.86 | 100,000 | 1,686,000 | 100,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | A | 16.86 | 15,000 | 252,900 | 15,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 16.86 | 50,000 | 843,000 | 50,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Option Exercise | A | 16.86 | 50,000 | 843,000 | 50,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 16.86 | 200,000 | 3,372,000 | 200,000 | |
| Jun 06 2014 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Option Exercise | M | 0.50 | 37,500 | 18,750 | 0 | |
| Jun 06 2014 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Buy | M | 0.50 | 37,500 | 18,750 | 275,000 | 237.5 K to 275 K (+15.79 %) |
| May 29 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 5,000 | 75,000 | 101,500 | 106.5 K to 101.5 K (-4.69 %) |
| May 23 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 4,306 | 64,590 | 106,500 | 110.8 K to 106.5 K (-3.89 %) |
| May 23 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 14.99 | 1,694 | 25,393 | 110,806 | 112.5 K to 110.8 K (-1.51 %) |
| Mar 24 2014 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 18.56 | 20,000 | 371,200 | 20,000 | |
| Mar 24 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 18.56 | 20,000 | 371,200 | 20,000 | |
| Feb 05 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | P | 17.50 | 28,571 | 499,993 | 240,955 | 212.4 K to 241 K (+13.45 %) |
| Dec 18 2013 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 0.30 | 12,500 | 3,750 | 0 | |
| Dec 18 2013 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 0.30 | 12,500 | 3,750 | 112,500 | 100 K to 112.5 K (+12.50 %) |